Mink Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Mink Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mink Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mink Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $17k | 18k | 0.95 |
| 2024-03-31 | $14k | 16k | 0.91 |
| 2023-12-31 | $22k | 20k | 1.07 |
| 2023-09-30 | $19k | 17k | 1.10 |
| 2023-06-30 | $36k | 17k | 2.10 |